Home › Therapeutic areas › Neurology › Tourette Syndrome
Tourette Syndrome (2 companies)
Companies with an active program in Tourette Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics | Neurology Rare | 1 | Approved | $6.96B | 15 |
| RLMD | Relmada Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | $416M | 4 |
No companies match.